Patent Yard Sign in
Canadian application, no grantCanada

Production and purification of recombinant human interleukin-3 and muteins thereof

CA 2028827 A1 · Owner: Van Leen, Robert W. · Inventors: Persoon, Nicolaas L. M.; Van Leen, Robert W.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

of the Invention, Recombinantly produced IL-3 is purified in a series of steps, initially employing hydrophobic interaction followed by ion-exchange chromatography and gel filtration. Furthermore methods are provided for improved production of recombinant hIL -3 either in glycosylated form from mammalian and yeast cells or in unglycosylated form from prokaryotes.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 15, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 15, 2010.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 15, 2012.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 15, 1990
GrantedNo grant recorded
Term endedMarch 15, 2010
Patent numberCA 2028827 A1
Classification (IPC)C12N15/24 +2 more

Timeline

Timeline From CIPO dates

1991199319951997199920012003200520072009Application filedMarch 15, 1990Term endedMarch 15, 2010

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.